Contributions
2,972 recent contributions in Hansard
HANSARDAstraZenecaAs I have already said, we had £63 billion of investment at the summit before Christmas, and we have had £14 billion of investment since Christmas. I have a specific…03 Feb 2025HANSARDAstraZenecaYes, and I agree with everything my hon. Friend says. The Oxford-Cambridge corridor is really important. Reading the newspapers over the weekend, I was intrigued by how many…03 Feb 2025HANSARDAstraZenecaI will take support from wherever I can get it, so I am grateful to the right hon. Gentleman. It is a very simple point that when the Government invest in businesses of whatever…03 Feb 2025HANSARDAstraZenecaMy hon. Friend is right: not only do we need to enable smaller companies to start up, but we need to enable them to grow to scale. Otherwise, the danger is that we develop the…03 Feb 2025HANSARDAstraZenecaIt is not entirely dependent on our AstraZeneca programme, and indeed, as I have already pointed out, the piece of work in which it was intending to invest—I hope I will get the…03 Feb 2025HANSARDAstraZenecaThere are all sorts of bids coming in now, none of which I am in charge of, but we have seen significant added investments in the UK since the autumn. For instance, Iberdrola is…03 Feb 2025HANSARDAstraZenecaThe thing is that spending taxpayers’ money has to be proven to be good value for money. That is why, whenever we are making an investment such as this, we have to make sure it…03 Feb 2025HANSARDAstraZenecaNot only have we set aside £520 million precisely to be able to invest in the life sciences industry with an innovation fund, we are very keen to work with specific businesses to…03 Feb 2025HANSARDAstraZenecaIf I might just refer to the first comment first, I am the Member for Rhondda and Ogmore, so I fully understand that investment in one part of the country is obviously great for…03 Feb 2025HANSARDAstraZenecaThe hon. Lady’s first point was on the voluntary scheme for branded medicines pricing and access, which is reduced to an acronym that is not really an acronym: VPAG. This is, as…03 Feb 2025HANSARDAstraZenecaI would be delighted to meet my hon. Friend knows, as she knows, although I think it would probably be more useful for her if she were to meet Lord Vallance, who is the Minister…03 Feb 2025HANSARDAstraZenecaNo.03 Feb 2025HANSARDAstraZenecaNot necessarily for this specific deal, but certainly for a deal with AstraZeneca, yes.03 Feb 2025HANSARDAstraZenecaThe right hon. Lady puts it in a particular way, but it is not a way that is consonant with the facts. The fact is that this deal had not been signed or got over the line by the…03 Feb 2025HANSARDAstraZenecaThat is the cleverest bid for finance that I have ever heard, so my hon. Friend gets an award for that. She is right that we stand ready at any point to assist key investments of…03 Feb 2025HANSARDAstraZenecaOf course we feel regretful. We would have preferred to get this over the line but that was not possible, in large measure because AstraZeneca decided that it did not add up in…03 Feb 2025HANSARDAstraZenecaYes, 100%. I know that my hon. Friend has visited AstraZeneca and spoken to it many times. He is absolutely right to note that there are, I think, 4,000 working at the…03 Feb 2025HANSARDAstraZenecaRegional mayors have an important role to play in helping bring investment into key areas. I am happy to ensure that the meetings that my hon. Friend has asked for take place.…03 Feb 2025HANSARDAstraZenecaI am afraid that I will have to write to the hon. Lady on that last question, as I am not sure precisely where we are with an impact assessment. She is absolutely right that the…03 Feb 2025HANSARDAstraZenecaIt is good to hear from the Chair of the Select Committee. I want to make it absolutely clear that AstraZeneca is not leaving—people are not losing their jobs because of this…03 Feb 2025